We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $15.3B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12B
AUM Growth
+$2B
Cap. Flow
+$2.04B
Cap. Flow %
17.04%
Top 10 Hldgs %
49.1%
Holding
107
New
26
Increased
43
Reduced
12
Closed
21

Top Buys

1
COL
Rockwell Collins
COL
+$391M
2
MON
Monsanto Co
MON
+$386M
3
KDP icon
Keurig Dr Pepper
KDP
+$362M
4
LOGM
LogMein, Inc.
LOGM
+$212M
5
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$182M

Top Sells

1
TWX
Time Warner Inc
TWX
+$306M
2
AABA
Altaba Inc
AABA
+$248M
3
BUD icon
AB InBev
BUD
+$164M
4
CPN
Calpine Corporation
CPN
+$163M
5
HUN icon
Huntsman Corp
HUN
+$80.7M

Sector Composition

1 Technology 25.94%
2 Healthcare 17.57%
3 Communication Services 16.49%
4 Financials 13.71%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
76
Grifois
GRFS
$4.9B
$8.33M 0.07%
392,804
-1,015,956
-72% -$23.1M
MRTX
77
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.29M 0.07%
+270,000
New +$7.49M
CBAY
78
DELISTED
Cymabay Therapeutics
CBAY
$7.14M 0.06%
550,000
-550,000
-50% -$6.83M
VICI icon
79
VICI Properties
VICI
$29.1B
$6.07M 0.05%
+337,049
New +$6.59M
XNCR icon
80
Xencor
XNCR
$1.11B
$4.49M 0.04%
+149,900
New +$3.92M
CBIO
81
Crescent Biopharma
CBIO
$433M
$4.06M 0.03%
+2,500
New +$5.2M
TYME
82
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$3.19M 0.03%
+1,430,289
New +$5.83M
GCVRZ
83
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.88M 0.02%
6,827,805
– –
RCUS icon
84
Arcus Biosciences
RCUS
$3.53B
$176K ﹤0.01%
+11,422
New +$190K
ABBV icon
85
AbbVie
ABBV
$438B
– –
-700,000
Closed -$67.7M
AKBA icon
86
Akebia Therapeutics
AKBA
$370M
– –
-825,000
Closed -$12.3M
ANAB icon
87
AnaptysBio
ANAB
$2.07B
– –
-561,000
Closed -$56.5M
ASMB icon
88
Assembly Biosciences
ASMB
$534M
– –
-20,833
Closed -$11.3M
BKD icon
89
Brookdale Senior Living
BKD
$3.44B
– –
-330,000
Closed -$3.2M
BMY icon
90
Bristol-Myers Squibb
BMY
$121B
– –
-1,192,500
Closed -$73.1M
BUD icon
91
AB InBev
BUD
$153B
– –
-1,470,192
Closed -$164M
EDIT icon
92
Editas Medicine
EDIT
$485M
– –
-515,000
Closed -$15.8M
HUN icon
93
Huntsman Corp
HUN
$2.04B
– –
-2,425,000
Closed -$80.7M
IONS icon
94
Ionis Pharmaceuticals
IONS
$9.38B
– –
-645,000
Closed -$32.4M
KALA icon
95
KALA BIO
KALA
$20.3M
– –
-74
Closed -$3.42M
LUMN icon
96
Lumen
LUMN
$6.65B
– –
0
– –
NCNA
97
NuCana
NCNA
$5.33M
– –
-80
Closed -$4.04M
SPB icon
98
Spectrum Brands
SPB
$1.95B
– –
-170,000
Closed -$19.1M
SPY icon
99
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
0
– –
MRNS
100
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-223,750
Closed -$7.3M
1 2 3
4
5

Similar funds

UM
UniSuper Management Melbourne, Victoria, Australia $15.3B AUM 29.4% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.4B AUM 18.35% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return